tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CYTK Stock Latest News

Cytokinetics Announces Upcoming Presentations at the HCMS Scientific Sessions and the HFSA Annual Scientific Meeting
Press ReleasesCytokinetics Announces Upcoming Presentations at the HCMS Scientific Sessions and the HFSA Annual Scientific Meeting
7h ago
CYTK
Edgewise Therapeutics price target raised to $42 from $32 at Leerink
PremiumThe Fly
Edgewise Therapeutics price target raised to $42 from $32 at Leerink
9h ago
BMY
CYTK
Cytokinetics announces data from Phase 1 study of CK-4021586
PremiumThe Fly
Cytokinetics announces data from Phase 1 study of CK-4021586
11d ago
CYTK
Cytokinetics Announces Data From Phase 1 Study of CK-4021586
PremiumPress Releases
Cytokinetics Announces Data From Phase 1 Study of CK-4021586
11d ago
CYTK
Cytokinetics Announces Two Presentations at the 2024 American College of Clinical Pharmacology Annual Meeting
PremiumPress Releases
Cytokinetics Announces Two Presentations at the 2024 American College of Clinical Pharmacology Annual Meeting
14d ago
CYTK
Cytokinetics price target raised to $71 from $65 at JPMorgan
PremiumThe FlyCytokinetics price target raised to $71 from $65 at JPMorgan
15d ago
CYTK
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Premium
Press Releases
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15d ago
CYTK
Cytokinetics presents new safety, long-term use data of aficamten
Premium
The Fly
Cytokinetics presents new safety, long-term use data of aficamten
18d ago
CYTK
Cytokinetics presents additional data from SEQUOIA-HCM
PremiumThe Fly
Cytokinetics presents additional data from SEQUOIA-HCM
18d ago
CYTK
Cytokinetics Presents New Data Related to the Safety and Long-Term Use of Aficamten at the European Society of Cardiology Congress 2024
PremiumPress Releases
Cytokinetics Presents New Data Related to the Safety and Long-Term Use of Aficamten at the European Society of Cardiology Congress 2024
19d ago
CYTK
Cytokinetics Presents Additional Data From SEQUOIA-HCM at the European Society of Cardiology Congress 2024
PremiumPress Releases
Cytokinetics Presents Additional Data From SEQUOIA-HCM at the European Society of Cardiology Congress 2024
19d ago
CYTK
Cytokinetics to Participate in September Investor Conferences
PremiumPress Releases
Cytokinetics to Participate in September Investor Conferences
21d ago
CYTK
Cytokinetics Names Brett Pletcher EVP and Chief Legal Officer
PremiumCompany AnnouncementsCytokinetics Names Brett Pletcher EVP and Chief Legal Officer
1M ago
8K
CYTK
Warner Bros. downgraded, Starbucks upgraded: Wall Street’s top analyst calls
Premium
The Fly
Warner Bros. downgraded, Starbucks upgraded: Wall Street’s top analyst calls
1M ago
FR
IT
Cytokinetics downgraded to Neutral from Buy at Goldman Sachs
Premium
The Fly
Cytokinetics downgraded to Neutral from Buy at Goldman Sachs
1M ago
CYTK
Truist biotech analyst holds an analyst/industry conference call
PremiumThe Fly
Truist biotech analyst holds an analyst/industry conference call
1M ago
BMY
CYTK
Options Volatility and Implied Earnings Moves Today, August 09, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, August 09, 2024
1M ago
AQN
AXL
Cytokinetics Reports Second Quarter 2024 Financial Results
PremiumPress Releases
Cytokinetics Reports Second Quarter 2024 Financial Results
1M ago
CYTK
Cytokinetics reports Q2 EPS ($1.31), consensus ($1.06)
PremiumThe Fly
Cytokinetics reports Q2 EPS ($1.31), consensus ($1.06)
1M ago
CYTK
CYTK Earnings this Week: How Will it Perform?
PremiumPre-EarningsCYTK Earnings this Week: How Will it Perform?
1M ago
CYTK
Cytokinetics announces call for proposals for Corporate Giving Program
Premium
The Fly
Cytokinetics announces call for proposals for Corporate Giving Program
2M ago
CYTK
Cytokinetics Announces Call for Proposals for Corporate Giving Program
Premium
Press Releases
Cytokinetics Announces Call for Proposals for Corporate Giving Program
2M ago
CYTK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >